Last Insurer Settles With Mylan In $67M Antitrust Appeal
Mylan Pharmaceuticals Inc. and a pair of chemical companies on Thursday settled with a Blue Cross Blue Shield affiliate, coming closer to ending their appeal of a $67 million verdict that...To view the full article, register now.
Already a subscriber? Click here to view full article